TY  - RPRT
TI  - Daily administration of low-dose daunorubicin or doxorubicin inhibits hypoxia-inducible factor 1 and tumor vascularization
AU  - Yang, Y.
AU  - Chen, D. Z.
AU  - Rey, S.
AU  - Liu, J. O.
AU  - Semenza, G. L.
PY  - 2022
DO  - 10.1101/2022.06.15.492526
UR  - https://www.biorxiv.org/content/10.1101/2022.06.15.492526v1
ID  - 10.1101/2022.06.15.492526
ER  -